Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/25/2007
 
First Published:
12/1/2001
1.
Phase III Randomized Study of Gabapentin in Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
NCI
NCCTG-N00C3
NCCTG-CCC-0020, NCI-P01-0196, NCT00027963
Last Modified:
12/7/2006
 
First Published:
1/1/2002
2.
Phase III Randomized Study of Gabapentin for the Management of Hot Flashes in Patients With Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
NCI
NCCTG-N00CB
NCI-P01-0199, N00CB, NCT00028574
Last Modified:
4/18/2007
 
First Published:
6/23/2004
3.
Phase III Randomized Study of Gabapentin With Versus Without Antidepressants for the Management of Hot Flashes in Women With a History of Breast Cancer or a Concern About Taking Hormonal Therapy Due to a Fear of Developing Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Completed
18 and over
NCI
NCCTG-N03C5
NCT00087399
4.
Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Completed
18 and over
Other
INST 3204C
NCT00250744
Last Modified:
7/5/2006
 
First Published:
8/1/2001
5.
Randomized Study of Gabapentin For the Control of Hot Flashes and Other Vasomotor Symptoms in Women With Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
Not specified
NCI
URCC-U2101
NCI-P01-0183, NCT00022074
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute